Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency

Patients with primary antibody deficiency are at risk for severe and in many cases for prolonged COVID-19. Convalescent plasma treatment of immunocompromised individuals could be an option especially in countries with limited access to monoclonal antibody therapies. While studies in immunocompetent...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang-Meli, Julia, Fuchs, Jonas, Mathé, Philipp, Ho, Hsi-en, Kern, Lisa, Jaki, Lena, Rusignuolo, Giuseppe, Mertins, Susanne, Somogyi, Vivien, Neumann-Haefelin, Christoph, Trinkmann, Frederik, Müller, Michael, Thimme, Robert, Umhau, Markus, Quinti, Isabella, Wagner, Dirk, Panning, Marcus, Cunningham-Rundles, Charlotte, Laubner, Katharina, Warnatz, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664001/
https://www.ncbi.nlm.nih.gov/pubmed/34893946
http://dx.doi.org/10.1007/s10875-021-01193-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664001/
https://www.ncbi.nlm.nih.gov/pubmed/34893946
http://dx.doi.org/10.1007/s10875-021-01193-2

Ejemplares similares